v2.4.0.8
STOCKHOLDERS' EQUITY STATEMENTS (USD $)
In Millions
Total
Common stock and paid-in capital
Retained earnings (deficit)
Accumulated other comprehensive income
Balance, beginning of period at Jun. 30, 2011   $ 63,415 $ (8,195) $ 1,863
Common stock issued   1,924    
Net income 16,978   16,978  
Other comprehensive income (loss) (441)     (441)
Common stock cash dividends     (6,721)  
Common stock repurchased   (1,714) (2,918)  
Stock-based compensation expense   2,244    
Stock-based compensation income tax benefits (deficiencies)   (75)    
Other, net   3    
Balance, end of period at Jun. 30, 2012 66,363 65,797 (856) 1,422
Common stock issued   920    
Net income 21,863 [1],[2]   21,863  
Other comprehensive income (loss) 321     321
Common stock cash dividends     (7,694)  
Common stock repurchased   (2,014) (3,418)  
Stock-based compensation expense   2,406    
Stock-based compensation income tax benefits (deficiencies)   190    
Other, net   7    
Balance, end of period at Jun. 30, 2013 78,944 67,306 9,895 1,743
Common stock issued   607    
Net income 22,074 [2],[3]   22,074  
Other comprehensive income (loss) 1,965     1,965
Common stock cash dividends     (9,271)  
Common stock repurchased   (2,328) (4,988)  
Stock-based compensation expense   2,446    
Stock-based compensation income tax benefits (deficiencies)   272    
Other, net   63    
Balance, end of period at Jun. 30, 2014 $ 89,784 $ 68,366 $ 17,710 $ 3,708
[1] Includes a charge related to a fine imposed by the European Commission in March 2013 which decreased net income by $733 million (€561 million) and diluted earnings per share by $0.09. Also includes a charge for Surface RT inventory adjustments recorded in the fourth quarter of fiscal year 2013, which decreased net income by $596 million and diluted earnings per share by $0.07.
[2] NDS has been included in our consolidated results of operations starting on April 25, 2014, the date of acquisition.
[3] Includes a tax provision adjustment recorded in the fourth quarter of fiscal year 2014 related to adjustments to prior years' liabilities for intercompany transfer pricing which decreased net income by $458 million and diluted earnings per share by $0.05.